In the BioHarmony Drug Report Database
Meglumine
Renovue (meglumine) is a small molecule pharmaceutical. Meglumine was first approved as Renovue on 1982-01-01. It is used to treat aids-related opportunistic infections, cutaneous leishmaniasis, and visceral leishmaniasis in the USA.
Trade Name
|
Renovue |
|---|---|
Common Name
|
meglumine |
ChEMBL ID
|
CHEMBL1200570 |
Indication
|
aids-related opportunistic infections, cutaneous leishmaniasis, visceral leishmaniasis |
Drug Class
|
Image (chem structure or protein)